Virios Therapeutics, Inc. (VIRI)
Largest Insider Buys in Sector
VIRI Stock Price History Chart
VIRI Stock Performance
About Virios Therapeutics, Inc.
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.
Insider Activity of Virios Therapeutics, Inc.
Over the last 12 months, insiders at Virios Therapeutics, Inc. have bought $51,237 and sold $0 worth of Virios Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Virios Therapeutics, Inc. have bought $170,786 and sold $466 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Duncan Gregory Scott (CHIEF EXECUTIVE OFFICER) — $31,245. Pridgen William (director) — $19,992.
The last purchase of 15,335 shares for transaction amount of $19,992 was made by Pridgen William (director) on 2023‑08‑21.
List of Insider Buy and Sell Transactions, Virios Therapeutics, Inc.
| 2023-08-21 | Pridgen William | director | 15,335 0.0833% | $1.30 | $19,992 | -61.64% | ||
| 2023-08-17 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | 25,000 0.1422% | $1.25 | $31,245 | -58.19% | ||
| 2022-12-08 | Sale | Whitley Richard James | director | 1,800 0.0156% | $0.26 | $466 | +176.91% | |
| 2022-05-23 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | 7,500 0.0917% | $4.52 | $33,900 | -91.26% | ||
| 2022-05-23 | Walsh Angela | SVP OF FINANCE | 2,000 0.0247% | $4.58 | $9,150 | -91.26% | ||
| 2022-05-18 | Pridgen William | 241 0.0028% | $4.50 | $1,085 | -91.51% | |||
| 2022-05-18 | Whitley Richard James | 500 0.0059% | $4.53 | $2,263 | -91.51% | |||
| 2022-05-17 | Pridgen William | 13,450 0.1561% | $4.38 | $58,914 | -91.43% | |||
| 2022-03-29 | Pridgen William | 600 0.0072% | $4.94 | $2,964 | -91.97% | |||
| 2022-03-23 | Pridgen William | 2,197 0.0273% | $5.46 | $12,002 | -91.37% | |||
| 2022-01-27 | Pridgen William | director | 4,180 0.052% | $5.98 | $24,998 | -26.43% | ||
| 2022-01-07 | De La Rosa Abel | director | 4,000 0.0503% | $5.90 | $23,584 | -22.64% | ||
| 2022-01-06 | Whitley Richard James | director | 1,800 0.0212% | $5.72 | $10,296 | -25.34% | ||
| 2022-01-04 | Keefer David R | director | 5,000 0.061% | $5.79 | $28,975 | -22.81% | ||
| 2022-01-04 | Thomas John C | director | 1,000 0.0119% | $5.65 | $5,650 | -22.81% | ||
| 2022-01-03 | Pridgen William | director | 2,215 0.0255% | $5.43 | $12,034 | -22.40% | ||
| 2021-12-23 | Whitley Richard James | director | 200 0.0024% | $5.72 | $1,145 | -20.32% | ||
| 2021-12-21 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | 5,000 0.0574% | $5.52 | $27,615 | -21.89% | ||
| 2021-12-21 | Pridgen William | director | 8,827 0.1039% | $5.66 | $49,997 | -21.89% | ||
| 2021-07-07 | Pridgen William | director | 942 0.0115% | $6.32 | $5,951 | -17.74% |
Insider Historical Profitability
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | 57461 0.2984% | $0.24 | 5 | 0 | <0.0001% |
| Pridgen William | director | 52045 0.2703% | $0.24 | 11 | 0 | <0.0001% |
| Keefer David R | director | 5000 0.026% | $0.24 | 1 | 0 | |
| De La Rosa Abel | director | 4000 0.0208% | $0.24 | 1 | 0 | |
| Walsh Angela | SVP OF FINANCE | 3000 0.0156% | $0.24 | 2 | 0 | <0.0001% |
| Thomas John C | director | 1000 0.0052% | $0.24 | 1 | 0 | |
| Whitley Richard James | director | 700 0.0036% | $0.24 | 3 | 1 |
Institutional Investor Ownership
| The Vanguard Group | $100,076.00 | 0.75 | 208,883 | 0% | +$0 | <0.0001 | |
| Geode Capital Management | $83,601.00 | 0.63 | 174,469 | 0% | +$0 | <0.0001 | |
| State Street | $25,310.00 | 0.19 | 52,828 | 0% | +$0 | <0.0001 | |
| Mccollum Christoferson Group Llc | $20,122.00 | 0.15 | 42,000 | +13.51% | +$2,395.48 | 0.01 | |
| Raymond James Associates | $14,373.00 | 0.11 | 30,000 | 0% | +$0 | <0.0001 | |
| Northern Trust | $11,515.00 | 0.09 | 24,035 | 0% | +$0 | <0.0001 | |
| Susquehanna International Group | $11,193.00 | 0.08 | 23,363 | New | +$11,193.00 | <0.0001 | |
| Regions Bank | $9,617.00 | 0.07 | 20,072 | 0% | +$0 | <0.0001 | |
| Northwestern Mutual Wealth Management Co | $9,133.00 | 0.07 | 19,062 | New | +$9,133.00 | <0.0001 | |
| Jane Street Capital | $8,144.00 | 0.06 | 16,998 | New | +$8,144.00 | <0.0001 | |
| Morgan Stanley | $7,187.00 | 0.05 | 15,000 | 0% | +$0 | <0.0001 | |
| Cetera Advisors LLC | $5,702.00 | 0.04 | 11,901 | -12.23% | -$794.86 | <0.0001 | |
| Wiley Bros. - Aintree Capital LLC | $5,270.00 | 0.04 | 11,000 | New | +$5,270.00 | <0.01 | |
| Group One Trading | $3,886.00 | 0.03 | 8,111 | -41.99% | -$2,812.81 | <0.0001 | |
| Tower Research Capital | $3,262.00 | 0.03 | 6,811 | +1.6% | +$51.25 | <0.0001 | |
| Cutler Group Lp | $1,000.00 | 0.01 | 2,300 | 0% | +$0 | <0.01 | |
| BlackRock | $362.00 | <0.01 | 755 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $64.00 | <0.01 | 133 | +2.31% | +$1.44 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 56 | 0% | +$0 | <0.0001 |